Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Becker

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Bioorganic & Medicinal Chemistry|March 9, 2026
N-aryl sulfonamide inhibitors of the bacterial enzyme diaminopimelate desuccinylase (DapE) as potential new antibioticsSebastian Flieger, Emma H Kelley, Thahani S Habeeb Mohammad, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2011
MMP-13 selective alpha-sulfone hydroxamates: identification of selective P1' amidesYvette M Fobian, John N Freskos, Thomas E Barta, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2011
MMP-13 selective α-sulfone hydroxamates: a survey of P1' heterocyclic amide isosteresThomas E Barta, Daniel P Becker, Louis J Bedell, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2010
Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamatesStephen A Kolodziej, Susan L Hockerman, Terri L Boehm, et al.
The Journal of Biological Chemistry|February 23, 2013
Large scale structural rearrangement of a serine hydrolase from Francisella tularensis facilitates catalysisEkaterina V Filippova, Leigh A Weston, Misty L Kuhn, et al.
Methods (San Diego, Calif.)|January 16, 2021
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assaysYash Gupta, Dawid Maciorowski, Samantha E Zak, et al.
Journal of Medicinal Chemistry|October 14, 2005
Synthesis and structure-activity relationships of beta- and alpha-piperidine sulfone hydroxamic acid matrix metalloproteinase inhibitors with oral antitumor efficacyDaniel P Becker, Clara I Villamil, Thomas E Barta, et al.
Journal of Medicinal Chemistry|August 24, 2010
Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular diseaseDaniel P Becker, Thomas E Barta, Louis J Bedell, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Bioorganic & Medicinal Chemistry|March 9, 2026
N-aryl sulfonamide inhibitors of the bacterial enzyme diaminopimelate desuccinylase (DapE) as potential new antibioticsSebastian Flieger, Emma H Kelley, Thahani S Habeeb Mohammad, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2011
MMP-13 selective alpha-sulfone hydroxamates: identification of selective P1' amidesYvette M Fobian, John N Freskos, Thomas E Barta, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2011
MMP-13 selective α-sulfone hydroxamates: a survey of P1' heterocyclic amide isosteresThomas E Barta, Daniel P Becker, Louis J Bedell, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2010
Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamatesStephen A Kolodziej, Susan L Hockerman, Terri L Boehm, et al.
The Journal of Biological Chemistry|February 23, 2013
Large scale structural rearrangement of a serine hydrolase from Francisella tularensis facilitates catalysisEkaterina V Filippova, Leigh A Weston, Misty L Kuhn, et al.
Methods (San Diego, Calif.)|January 16, 2021
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assaysYash Gupta, Dawid Maciorowski, Samantha E Zak, et al.
Journal of Medicinal Chemistry|October 14, 2005
Synthesis and structure-activity relationships of beta- and alpha-piperidine sulfone hydroxamic acid matrix metalloproteinase inhibitors with oral antitumor efficacyDaniel P Becker, Clara I Villamil, Thomas E Barta, et al.
Journal of Medicinal Chemistry|August 24, 2010
Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular diseaseDaniel P Becker, Thomas E Barta, Louis J Bedell, et al.
Pageof 5